Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic
Vincent Chi-Chung Cheng,
Shuk-Ching Wong,
Simon Yung-Chun So,
Jonathan Hon-Kwan Chen,
Pui-Hing Chau,
Albert Ka-Wing Au,
Kelvin Hei-Yeung Chiu,
Xin Li,
Patrick Ip,
Vivien Wai-Man Chuang,
David Christopher Lung,
Cindy Wing-Sze Tse,
Rodney Allan Lee,
Kitty Sau-Chun Fung,
Wing-Kin To,
Raymond Wai-Man Lai,
Tak-Lun Que,
Janice Yee-Chi Lo,
Kwok-Yung Yuen
Affiliations
Vincent Chi-Chung Cheng
Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong, China
Shuk-Ching Wong
Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong, China
Simon Yung-Chun So
Department of Microbiology, Queen Mary Hospital, Hong Kong, China
Jonathan Hon-Kwan Chen
Department of Microbiology, Queen Mary Hospital, Hong Kong, China
Pui-Hing Chau
School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Albert Ka-Wing Au
Centre for Health Protection, Department of Health, Hong Kong, China
Kelvin Hei-Yeung Chiu
Department of Microbiology, Queen Mary Hospital, Hong Kong, China
Xin Li
Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Patrick Ip
Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Vivien Wai-Man Chuang
Quality & Safety Division, Hospital Authority, Hong Kong, China
David Christopher Lung
Department of Pathology, Queen Elizabeth Hospital, Hong Kong, China
Cindy Wing-Sze Tse
Department of Pathology, Kwong Wah Hospital, Hong Kong, China
Rodney Allan Lee
Department of Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China
Kitty Sau-Chun Fung
Department of Pathology, United Christian Hospital, Hong Kong, China
Wing-Kin To
Department of Pathology, Princess Margaret Hospital, Hong Kong, China
Raymond Wai-Man Lai
Quality & Safety Division, Hospital Authority, Hong Kong, China
Tak-Lun Que
Department of Pathology, Tuen Mun Hospital, Hong Kong, China
Janice Yee-Chi Lo
Centre for Health Protection, Department of Health, Hong Kong, China
Kwok-Yung Yuen
Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Nonpharmaceutical interventions implemented during the COVID-19 pandemic (2020–2021) have provided a unique opportunity to understand their impact on the wholesale supply of antibiotics and incidences of infections represented by bacteremia due to common bacterial species in Hong Kong. The wholesale antibiotic supply data (surrogate indicator of antibiotic consumption) and notifications of scarlet fever, chickenpox, and tuberculosis collected by the Centre for Health Protection, and the data of blood cultures of patients admitted to public hospitals in Hong Kong collected by the Hospital Authority for the last 10 years, were tabulated and analyzed. A reduction in the wholesale supply of antibiotics was observed. This decrease coincided with a significant reduction in the incidence of community-onset bacteremia due to Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, which are encapsulated bacteria with respiratory transmission potential. This reduction was sustained during two pandemic years (period 2: 2020–2021), compared with eight pre-pandemic years (period 1: 2012–2019). Although the mean number of patient admissions per year (1,704,079 vs. 1,702,484, p = 0.985) and blood culture requests per 1000 patient admissions (149.0 vs. 158.3, p = 0.132) were not significantly different between periods 1 and 2, a significant reduction in community-onset bacteremia due to encapsulated bacteria was observed in terms of the mean number of episodes per year (257 vs. 58, p p p Staphylococcus aureus or Escherichia coli. Sustained implementation of non-pharmaceutical interventions against respiratory microbes may reduce the overall consumption of antibiotics, which may have a consequential impact on antimicrobial resistance. Rebound of conventional respiratory microbial infections is likely with the relaxation of these interventions.